This past week, the University at Buffalo, Hauptman-Woodward and Roswell Park Cancer Institute were awarded federal grants for research and development. The University at Buffalo and Hauptman-Woodward Medical Research Institute received a $25-million Science and Technology Center grant from the National Science Foundation. Roswell Park Cancer Institute received new federal grants and other awards totaling nearly $7 million.
The University at Buffalo and Hauptman-Woodward Medical Research Institute grant will help them to lead the design of a major research to transform the field of structural biology, including drug development, using X-ray lasers. The grant will also help to create the BioXFEL Research Center as a multi-institution collaboration with eight other institutions nationwide. Eaton E. Lattman, PhD, professor in the UB Department of Structural Biology in the School of Medicine and Biomedical Sciences and chief executive officer of the Hauptman-Woodward Medical Research Institute (HWI), will serve as the director of the BioXFEL center, which will be headquartered in HWI and UB’s Department of Structural Biology.
Roswell Park Cancer Institute nearly $7 million in grant funding from federal agencies and other sources through several faculty members. The awards will help fund vital research that aims to develop new methods to prevent and treat cancer and to improve the patients’ quality of life. Dr. Kelvin Lee, chairman of the department of immunology, was awarded three grants worth a combined $3.9 million. Two of the grants are from the National Institute of Allergy and Infectious Diseases (NIAID) and will help fund Dr. Lee’s work in immunology. Dr. Lee also received a five-year grant from the National Cancer Institute (NCI) for $1.56 million to learn what specific molecular pathways are essential for multiple myeloma cancer cells to survive. Additionally, eight other Roswell scientists were also awarded grants funding.
Photo © 2013 University at Buffalo | Douglas Levere